Fairman Group, LLC Procept Bio Robotics Corp Transaction History
Fairman Group, LLC
- $98.4 Billion
- Q2 2024
A detailed history of Fairman Group, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Fairman Group, LLC holds 2,000 shares of PRCT stock, worth $126,640. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$126,640
Previous $98.8 Million
23.61%
% of portfolio
0.12%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
183Shares Held
37.7MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$337 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$269 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$208 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$186 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$126 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.82B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...